Screener
Celldex Therapeutics CLDX Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Celldex Therapeutics’s reported figures.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
FAQ
- What is Celldex Therapeutics's invested capital?
- Celldex Therapeutics (CLDX) reported invested capital of $672.01M in Q2 2026.
- How has Celldex Therapeutics's invested capital changed year-over-year?
- Celldex Therapeutics's invested capital increased by 5.8% year-over-year, from $635.39M to $672.01M.
- What is the long-term trend for Celldex Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Celldex Therapeutics's invested capital has grown at a 24.3% compound annual growth rate (CAGR), from $169M to $500.63M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Celldex Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude